Atherosclerosis and Inflammation: Why Plaque Is an Inflammatory Disease

Atherosclerosis is the underlying disease behind most heart attacks and many strokes. It develops as fatty deposits, called plaques, accumulate within the walls of arteries, gradually narrowing them and, more dangerously, creating unstable structures that can rupture and trigger clots. Because cholesterol is a visible ingredient in these plaques, the disease was long framed as a plumbing problem, with cholesterol simply building up on artery walls the way limescale coats a pipe.

That framing turned out to be incomplete. Modern vascular biology recognizes atherosclerosis as an active, inflammatory process in which the immune system is engaged from the very first steps through to the final rupture that causes a clinical event. Cholesterol is still central, but it is the inflammatory response to cholesterol that transforms a deposit into a dangerous, evolving lesion. This shift in understanding has reshaped how researchers think about prevention and treatment, and it is why an inflammatory marker like CRP features so prominently in cardiovascular research.

How an Inflammatory Plaque Forms

It starts with LDL entering the wall. The process begins when LDL cholesterol particles cross the thin inner lining of an artery, the endothelium, and become trapped in the wall beneath it. Once there, these particles are chemically modified, most importantly through oxidation. Oxidized LDL is not just a passive deposit; it is a danger signal that the immune system recognizes as something that should not be there, and it activates the endothelium to begin recruiting immune cells.

Immune cells move in. In response, circulating monocytes stick to the activated endothelium and migrate into the artery wall, where they mature into macrophages. These macrophages engulf the oxidized LDL in an attempt to clear it, but they take up so much that they become bloated, lipid-filled cells known as foam cells. Foam cells are the hallmark of the earliest visible lesion, the fatty streak. Crucially, as they accumulate cholesterol they also release pro-inflammatory cytokines that recruit still more immune cells, creating a self-reinforcing inflammatory loop within the wall.

The plaque matures. Over years, the lesion grows into a mature plaque with a core of dead cells, cholesterol crystals, and debris, covered by a fibrous cap of smooth muscle cells and connective tissue. Inflammatory signaling shapes this structure at every stage. Cytokines influence whether the cap stays thick and stable or thins and becomes vulnerable. The plaque is not a static clog but a living, remodeling tissue governed substantially by the balance of inflammatory and repair signals within it.

The Cytokine Cascade and the Danger of Rupture

IL-6 and the inflammatory signal. Among the inflammatory messengers driving atherosclerosis, interleukin-6 (IL-6) holds a central place. Released within plaques and by other tissues, IL-6 travels to the liver and stimulates the production of acute-phase proteins, including CRP. This IL-6 to CRP pathway is one reason blood levels of CRP can serve as a distant readout of the inflammatory activity happening inside artery walls. IL-1 beta, another key cytokine, sits upstream and helps ignite this cascade.

Why some plaques rupture. The gravest consequence of atherosclerosis is not the gradual narrowing of an artery but the sudden rupture of a plaque. Inflammatory cells within a plaque secrete enzymes called matrix metalloproteinases that degrade the fibrous cap. When the cap becomes thin enough, it can tear, exposing the highly clot-promoting core to the bloodstream. The resulting clot can abruptly block the artery, causing a heart attack, or in the arteries feeding the brain, a stroke. This is why the most inflamed plaques, rather than simply the largest, are often the most dangerous.

The role of the NLRP3 inflammasome. One reason cholesterol provokes such a strong inflammatory response is that cholesterol crystals forming within the plaque can activate a cellular alarm system called the NLRP3 inflammasome inside macrophages. Once triggered, this complex drives the production of active IL-1 beta, the very cytokine upstream of the IL-6 to CRP cascade. This gives a molecular explanation for how the cholesterol at the heart of a plaque directly ignites inflammation, tying the lipid and immune stories together at the level of a single cellular sensor.

A disease shared across the body. Because atherosclerosis is systemic, the same inflammatory process underlies coronary artery disease, carotid disease, and peripheral artery disease. It is also deeply intertwined with the broader inflammatory biology of heart disease and with the systemic low-grade inflammation associated with obesity, diabetes, and metabolic syndrome. Understanding plaque as an inflammatory lesion helps explain why conditions that raise whole-body inflammation also accelerate arterial disease.

CRP and the Evidence That Inflammation Matters

CRP as a window into the wall. Because CRP rises in response to the IL-6 signaling that emanates from inflamed tissue, high-sensitivity CRP measurements have been studied extensively as a marker of cardiovascular risk. In large cohorts, higher CRP is associated with greater risk of heart attack and stroke, and this association holds even among people whose cholesterol levels appear acceptable. CRP does not replace cholesterol testing; rather, it adds a complementary view of the inflammatory dimension of risk.

The CANTOS trial. A landmark step in confirming inflammation's causal role came from the CANTOS trial, which tested canakinumab, a drug that specifically blocks IL-1 beta, in patients who had already had a heart attack and had elevated CRP. Because canakinumab lowers inflammation without affecting cholesterol, the trial could isolate the effect of dampening inflammation itself. It found that reducing inflammation was associated with fewer subsequent cardiovascular events, providing some of the strongest evidence that inflammation is not merely a marker but an active contributor to atherosclerotic disease.

What the trials taught, and their limits. Subsequent research has continued to explore anti-inflammatory approaches to cardiovascular disease, including studies of low-dose colchicine and other agents. Not every anti-inflammatory strategy has succeeded, which underscores that inflammation is complex and that broadly suppressing the immune system carries its own risks. The overall body of evidence, however, has firmly established the inflammatory hypothesis of atherosclerosis and made inflammatory markers a meaningful part of how vascular risk is understood.

Cooling Arterial Inflammation

Lower LDL, lower the fuel. Because oxidized LDL is the initial spark, reducing LDL cholesterol remains foundational. Statins lower LDL and also carry independent anti-inflammatory effects, which is thought to contribute to their benefit; notably, statins tend to lower CRP as well as cholesterol. This dual action illustrates how closely lipid and inflammatory biology are linked in the artery wall. Medication decisions should always be made with a healthcare provider.

An anti-inflammatory lifestyle. Daily habits shape arterial inflammation substantially. An anti-inflammatory diet emphasizing vegetables, fruits, whole grains, legumes, olive oil, and fatty fish is associated with lower inflammatory markers and healthier vascular function. Regular physical activity reduces systemic inflammation and improves the health of the endothelium. Not smoking is essential, since tobacco smoke is a potent driver of vascular inflammation and endothelial injury.

Address the whole metabolic picture. Because conditions like obesity, high blood pressure, and elevated blood sugar all amplify arterial inflammation, managing them protects the arteries directly. Adequate sleep and stress management matter too, since both chronic stress and poor sleep tilt the immune system toward a pro-inflammatory state that the arteries feel. These interventions work together to cool the inflammatory environment in which plaque grows.

Consistency over intensity. What matters most for arterial inflammation is the sustained pattern of daily choices rather than any single dramatic intervention. Because atherosclerosis develops silently over decades, the inflammatory tone the arteries experience day after day is what shapes the trajectory of the disease. Small, durable habits, a mostly plant-forward plate, a daily walk, refusing cigarettes, and steady sleep, add up over years in a way that occasional bursts of effort cannot. This long view is exactly why an accessible marker that can be followed over time is valuable, since it lets a person watch the cumulative effect of their habits rather than guessing.

Resolution, not just suppression. An emerging theme in vascular biology is that healthy arteries depend not only on avoiding inflammation but on actively resolving it. The body produces specialized molecules, some derived from omega-3 fatty acids, that help switch off the inflammatory response and return tissue to a calm state. When this resolution process falters, inflammation in the artery wall becomes chronic and unresolved, allowing plaques to progress. This is one reason interest has grown in dietary factors like omega-3-rich foods that may support the body's natural capacity to resolve inflammation rather than merely blunt it.

The value of tracking a marker. Since arterial inflammation is invisible and builds over years, an inflammatory marker like CRP offers one of the few accessible windows into the process. A single value is only a snapshot, but following the trend over time can reveal whether lifestyle and medical changes are moving inflammation in a favorable direction. Interpreted alongside cholesterol, blood pressure, and other data by a healthcare provider, it enriches the overall picture of cardiovascular health.